Literature DB >> 8514973

Acromegaly: an epidemiological study.

J Etxabe1, S Gaztambide, P Latorre, J A Vazquez.   

Abstract

Although morbility and mortality in acromegaly are higher than in the general population, there have been very few previous epidemiological studies. This study tries to answer "why". Seventy-four patients affected by acromegaly in Vizcaya (Spain) between 1970 and 1989 were considered for an epidemiological study. The prevalence of known cases at the end of 1989 was 60 per million inhabitants. The average incidence of newly diagnosed cases was 3.1 per million people per year. Unexpectedly, acromegaly was more frequent in women (n = 48) than in men (n = 26), with a ratio of 1.8:1. Mean age at diagnosis was significantly higher in women (46.1 +/- 2.2 yr) than in men (39.5 +/- 2.2 yr) (p < 0.05) There was a positive correlation between age at diagnosis and the estimated duration of the disease (r = 0.56, p < 0.05) and a negative one between age and basal GH serum levels (r = -0.52 p < 0.002). The age at diagnosis was significantly higher in patients with invasive tumors (grade III and IV) than in those with enclosed tumors (grade I and II) (47.7 +/- 1.8 vs 40.1 +/- 3.3 p < 0.05). In general, mortality was higher than the expected for the control population (standardized mortality ratio, SMR = 3.2, 95% confidence interval. Cl = 1.55-5.93). However, mortality was higher in men (SMR = 7, 95% Cl = 2.81-14.4) but not in women (SMR = 1.4 95% Cl = 0.29-4.17).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514973     DOI: 10.1007/BF03344942

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  36 in total

1.  Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984.

Authors:  B A Bengtsson; S Edén; I Ernest; A Odén; B Sjögren
Journal:  Acta Med Scand       Date:  1988

Review 2.  Acromegaly.

Authors:  S Melmed
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

3.  Transsphenoidal microhypophysectomy in acromegaly.

Authors:  H S U; C B Wilson; J B Tyrrell
Journal:  J Neurosurg       Date:  1977-12       Impact factor: 5.115

Review 4.  Sequelae to acromegaly: reversibility with treatment of the primary disease.

Authors:  S A Lieberman; A R Hoffman
Journal:  Horm Metab Res       Date:  1990-06       Impact factor: 2.936

Review 5.  Hormones and hypertension.

Authors:  R Fraser; D L Davies; J M Connell
Journal:  Clin Endocrinol (Oxf)       Date:  1989-12       Impact factor: 3.478

6.  Clinical and laboratory study of acromegaly: assessment before and one year after treatment.

Authors:  J A Kanis; F J Gillingham; P Harris; D B Horn; W M Hunter; A T Redpath; J A Strong
Journal:  Q J Med       Date:  1974-07

7.  Transsphenoidal surgery for acromegaly--long-term results in 100 patients.

Authors:  F Grisoli; T Leclercq; P Jaquet; M Guibout; J P Winteler; J Hassoun; F Vincentelli
Journal:  Surg Neurol       Date:  1985-05

Review 8.  Epidemiology of pituitary adenomas.

Authors:  E B Gold
Journal:  Epidemiol Rev       Date:  1981       Impact factor: 6.222

9.  Sex difference in the relation between sellar volume and basal and GH-releasing hormone stimulated GH in acromegaly.

Authors:  A E Smals; G F Pieters; A G Smals; P W Kloppenborg
Journal:  Acta Endocrinol (Copenh)       Date:  1988-03

10.  Ascertainment and natural history of treated acromegaly in Northern Ireland.

Authors:  C M Ritchie; A B Atkinson; A L Kennedy; A R Lyons; D S Gordon; T Fannin; D R Hadden
Journal:  Ulster Med J       Date:  1990-04
View more
  43 in total

1.  Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center.

Authors:  Susanna Bacigaluppi; Federico Gatto; Pasquale Anania; Nicola Luigi Bragazzi; Diego Criminelli Rossi; Giulia Benvegnu; Elena Nazzari; Renato Spaziante; Massimo Giusti; Diego Ferone; Gianluigi Zona
Journal:  Endocrine       Date:  2015-05-17       Impact factor: 3.633

Review 2.  Medical management of pituitary adenomas: the special case of management of the pregnant woman.

Authors:  Marcello Delano Bronstein; Luiz Roberto Salgado; Nina Rosa de Castro Musolino
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

3.  Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database.

Authors:  Federico Gatto; Gianluca Trifirò; Francesco Lapi; Francesco Cocchiara; Claudia Campana; Carlotta Dell'Aquila; Carmen Ferrajolo; Marica Arvigo; Claudio Cricelli; Massimo Giusti; Diego Ferone
Journal:  Endocrine       Date:  2018-05-24       Impact factor: 3.633

4.  Psychosocial morbidity in acromegaly: a study from India.

Authors:  Surendra Kumar Mattoo; Anil Kumar Bhansali; Nitin Gupta; Sandeep Grover; Ramma Malhotra
Journal:  Endocrine       Date:  2008-10-25       Impact factor: 3.633

5.  Insulin-like growth factor-1 is essential to the increased mortality caused by excess growth hormone: a case of thyroid cancer and non-Hodgkin's lymphoma in a patient with pituitary acromegaly.

Authors:  A Taslipinar; E Bolu; L Kebapcilar; M Sahin; G Uckaya; M Kutlu
Journal:  Med Oncol       Date:  2008-07-29       Impact factor: 3.064

6.  Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis.

Authors:  Theodoros Rokkas; Dimitrios Pistiolas; Panos Sechopoulos; Georgios Margantinis; Georgios Koukoulis
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

Review 7.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

Review 8.  Management of acromegaly: is there a role for primary medical therapy?

Authors:  Zachary M Bush; Mary Lee Vance
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

9.  Absence of periodontitis in acromegalic patients.

Authors:  Danilo Lopes Ferreira Lima; Renan Magalhães Montenegro; Anya Pimentel Gomes Fernandes Vieira; Mônica Fiterman Albano; Delane Maria Rego
Journal:  Clin Oral Investig       Date:  2008-09-03       Impact factor: 3.573

Review 10.  Does acromegaly enhance mortality?

Authors:  John Ayuk; Michael C Sheppard
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.